BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Behboudi S, Pereira SP. Alpha-fetoprotein specific CD4 and CD8 T cell responses in patients with hepatocellular carcinoma. World J Hepatol 2010; 2(7): 256-260 [PMID: 21161007 DOI: 10.4254/wjh.v2.i7.256]
URL: https://www.wjgnet.com/2218-6190/full/v2/i7/256.htm
Number Citing Articles
Yiqiong Jia, Zhen Zeng, Yuanyuan Li, Zhiwei Li, Lei Jin, Zheng Zhang, Lifeng Wang, Fu-Sheng Wang, Xue-feng Bai. Impaired Function of CD4+ T Follicular Helper (Tfh) Cells Associated with Hepatocellular Carcinoma ProgressionPLOS ONE 2015; 10(2): e0117458 doi: 10.1371/journal.pone.0117458
Gianluigi Giannelli, Erica Villa, Michael Lahn. Transforming Growth Factor-β as a Therapeutic Target in Hepatocellular CarcinomaCancer Research 2014; 74(7): 1890 doi: 10.1158/0008-5472.CAN-14-0243
Su Jong Yu, Tim F. Greten. Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular CarcinomaJournal of Liver Cancer 2020; 20(1): 1 doi: 10.17998/jlc.20.1.1
Angela D. Pardee, Hiroshi Yano, Aliyah M. Weinstein, Aaron A. K. Ponce, Alexander D. Ethridge, Daniel P. Normolle, Lazar Vujanovic, Gerald J. Mizejewski, Simon C. Watkins, Lisa H. Butterfield. Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinomaJournal for ImmunoTherapy of Cancer 2015; 3(1) doi: 10.1186/s40425-015-0077-x
Hala S. El-Rebey, Asmaa G. Abdou, Mervat M. Sultan, Shymaa H. Ibrahim, Nanis S. Holah. The Profile and Role of Tumor-infiltrating Lymphocytes in Hepatocellular CarcinomaApplied Immunohistochemistry & Molecular Morphology 2020;  doi: 10.1097/PAI.0000000000000865
Angela D. Pardee, Jian Shi, Lisa H. Butterfield. Tumor-Derived α-Fetoprotein Impairs the Differentiation and T Cell Stimulatory Activity of Human Dendritic CellsThe Journal of Immunology 2014; 193(11): 5723 doi: 10.4049/jimmunol.1400725
Helal F. Hetta, Asmaa M. Zahran, Shima G. Mansor, Mohamed O. Abdel-Malek, Mohamed A. Mekky, Wael A. Abbas. Frequency and Implications of myeloid-derived suppressor cells and lymphocyte subsets in Egyptian patients with hepatitis C virus-related hepatocellular carcinomaJournal of Medical Virology 2019; 91(7): 1319 doi: 10.1002/jmv.25428
Wenkang Shang, Gabriel Komla Adzika, Yujie Li, Qike Huang, Ningding Ding, Bianca Chinembiri, Mohammad Sajjad Ibn Rashid, Jeremiah Ong'achwa Machuki. Molecular mechanisms of circular RNAs, transforming growth factor‐ β , and long noncoding RNAs in hepatocellular carcinoma Cancer Medicine 2019; 8(15): 6684 doi: 10.1002/cam4.2553
JUN ZHOU, PING MA, JUN LI, XIAONAN CUI, WEI SONG. Improvement of the cytotoxic T lymphocyte response against hepatocellular carcinoma by transduction of cancer cells with an adeno-associated virus carrying the interferon-γ geneMolecular Medicine Reports 2016; 13(4): 3197 doi: 10.3892/mmr.2016.4884
Tai Hato, Andrew X Zhu, Dan G Duda. Rationally combining anti-VEGF therapy with checkpoint inhibitors in hepatocellular carcinomaImmunotherapy 2016; 8(3): 299 doi: 10.2217/imt.15.126